Recent Advances in Hematological Malignancies in Children
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Pediatric Oncology".
Deadline for manuscript submissions: 30 December 2025
Special Issue Editor
Interests: pediatric hematology; the use of vibration spectroscopy in pediatric oncology; epigenetics in childhood leukemia; iron management
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common hematological malignancies in children. The progress made in their treatment over the past few decades, since the end of the 20th century, has been remarkable. Today, we are able to achieve long-term cures in 85-90% of children with ALL and 60-70% of those with AML, compared to approximately 10% in the 1970s. This advancement has been made possible through improved therapeutic protocols based on risk stratification, advancements in diagnostics and supportive care, as well as the introduction of stem cell transplantation, immunotherapy, and targeted therapies.
The purpose of this Special Issue "Recent Advances in Hematological Malignancies in Children" is to showcase the achievements in the treatment of pediatric ALL and AML in recent decades, with a particular focus on new diagnostic and therapeutic methods, including supportive care strategies, that have contributed to the improved outcomes in these malignancies. This Special Issue welcomes review articles as well as original research contributions. The deadline for submissions is 30 December 2025.
We look forward to your valuable contributions.
Dr. Radosław Chaber
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute lymphoblastic leukemia
- acute myeloid leukemia
- hematological malignancies in children
- diagnostic and therapeutic methods
- supportive care strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
